Drug Profile
J 104871
Latest Information Update: 08 Aug 2002
Price :
$50
*
At a glance
- Originator Banyu
- Class Antineoplastics
- Mechanism of Action Squalene synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Apr 1999 Preclinical development for Cancer in Japan (Unknown route)